EMORY UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
A Retrospective Analysis of the Predictive Potential of Pre-operative
Phase 2
Terminated
- Conditions
- Coronary Artery Bypass
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2013-09-27
- Lead Sponsor
- Emory University
- Target Recruit Count
- 600
- Registration Number
- NCT00321282
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Crawford Long Hospital, Atlanta, Georgia, United States
🇺🇸Veterans Administration Medical Center, Decatur, Georgia, United States
Assessment of Translesional Markers and Metabolomics
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2014-12-15
- Lead Sponsor
- Emory University
- Target Recruit Count
- 50
- Registration Number
- NCT00321139
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor
- First Posted Date
- 2006-04-13
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- Emory University
- Target Recruit Count
- 17
- Registration Number
- NCT00314262
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
Phase 1
Completed
- Conditions
- Myocardial InfarctionCoronary Artery Disease
- Interventions
- Drug: Intra-coronary infusion
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2013-11-18
- Lead Sponsor
- Emory University
- Target Recruit Count
- 31
- Registration Number
- NCT00313339
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Effects of Beta-adrenergic in Adults w/Transposition of Great Arteries on Systemic Ventricular Function
Completed
- Conditions
- Congenital Disorders
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- Emory University
- Target Recruit Count
- 110
- Registration Number
- NCT00313352
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Infectivity of Norovirus in Groundwater-Human Challenge Study
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Biological: Safety tested norovirus inoculum
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- Emory University
- Target Recruit Count
- 13
- Registration Number
- NCT00313404
- Locations
- 🇺🇸
Emory University General Clinical Research Center, Atlanta, Georgia, United States
Surgical Lavage vs Serial Needle Aspiration for Infected Joints
Phase 3
Withdrawn
- Conditions
- SepticArthritis
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2013-09-24
- Lead Sponsor
- Emory University
- Registration Number
- NCT00313365
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Risperdal Consta and Health Care Utilization in Patients With Schizophrenia
Phase 4
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Emory University
- Registration Number
- NCT00313391
- Locations
- 🇺🇸
Grady Hospital, Atlanta, Georgia, United States
Single Ventricle Outcome
Completed
- Conditions
- Hypoplastic Left Heart SyndromeHeart Disease, CongenitalSingle Ventricle
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2013-12-12
- Lead Sponsor
- Emory University
- Target Recruit Count
- 30
- Registration Number
- NCT00308217
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Pilot Study of B-Type Natrieutic Peptide (BNP) Levels in Patients With Congenital Heart Disease(BNP)
Not Applicable
Completed
- Conditions
- Cardiovascular DiseaseCongenital Heart Disease
- Interventions
- Procedure: Six minute walk testBehavioral: Minnesota Living with Heart Failure Questionnaire
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- Emory University
- Target Recruit Count
- 34
- Registration Number
- NCT00308230